Another study of electroconvulsive therapy in specific groups of patients with depression demonstrated, from a lateral perspective, that improvement in depressive behavior is associated with an increase in APOA1, a major component of HDL cholesterol (43). The gene discussed is APOA1; the disease is depressive disorder.